FDA outlines path for lower-priced biotech drugs
Thursday, February 9, 2012 - 18:00
in Health & Medicine
(AP) -- The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications which have never before faced generic competition.